{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:33:41Z","timestamp":1790656421108,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019123","name":"Operation Eyesight Universal Institute for Eye Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005809","name":"Hyderabad Eye Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.oret.2024.11.010","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T08:52:44Z","timestamp":1732006364000},"page":"589-597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Ayushi","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishakha","family":"Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1859-6629","authenticated-orcid":false,"given":"Vijitha S.","family":"Vempuluru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8446-2696","authenticated-orcid":false,"given":"Vishal","family":"Raval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0800-9961","authenticated-orcid":false,"given":"Swathi","family":"Kaliki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2024.11.010_bib1","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hyg113","article-title":"Eye-preservation treatment of retinoblastoma with vitreous seeding","volume":"33","author":"Kaneko","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.oret.2024.11.010_bib2","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/bjophthalmol-2011-301450","article-title":"Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1755-3768.1961.tb00269.x","article-title":"Present therapeutic resources in retinoblastoma","volume":"39","author":"Ericson","year":"1961","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib4","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/bjo.79.2.194","article-title":"Intravitreal chemotherapy for recurrent retinoblastoma in an only eye","volume":"79","author":"Seregard","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib5","first-page":"858","article-title":"Chemosensitivity profiles of primary and cultured human retinoblastoma cells in a human tumor clonogenic assay","volume":"78","author":"Inomata","year":"1987","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.oret.2024.11.010_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1136\/bjophthalmol-2011-301016","article-title":"Profiling safety of intravitreal injections for retinoblastoma using an anti-reflux procedure and sterilisation of the needle track","volume":"96","author":"Munier","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib7","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1001\/jamaophthalmol.2017.4600","article-title":"Risk of extraocular extension in eyes with retinoblastoma receiving intravitreous chemotherapy","volume":"135","author":"Francis","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib8","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archophthalmol.2012.1983","article-title":"Intravitreal melphalan for refractory or recurrent vitreous seeding from retinoblastoma","volume":"130","author":"Ghassemi","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/13816810.2014.973045","article-title":"Classification and management of seeds in retinoblastoma. Ellsworth Lecture Ghent August 24th 2013","volume":"35","author":"Munier","year":"2014","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oret.2024.11.010_bib10","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ophtha.2014.03.028","article-title":"Local and systemic toxicity of intravitreal melphalan for vitreous seeding in retinoblastoma: a preclinical and clinical study","volume":"121","author":"Francis","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.11.010_bib11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ophtha.2016.12.015","article-title":"Efficacy and toxicity of intravitreous chemotherapy for retinoblastoma: four-year experience","volume":"124","author":"Francis","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.11.010_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12886-019-1059-4","article-title":"Ocular toxicity of intravitreal melphalan for retinoblastoma in Chinese patients","volume":"19","author":"Xue","year":"2019","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000509080","article-title":"Intravitreal melphalan for retinoblastoma: the impact of toxicity on recurrence and ultimate globe salvage","volume":"6","author":"Berry","year":"2020","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.oret.2024.11.010_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1076\/opge.25.1.37.28996","article-title":"Activity of topotecan in retinoblastoma","volume":"25","author":"Chantada","year":"2004","journal-title":"Ophthalmicic Genets"},{"key":"10.1016\/j.oret.2024.11.010_bib15","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1167\/iovs.08-2737","article-title":"A phase I study of periocular topotecan in children with intraocular retinoblastoma","volume":"50","author":"Chantada","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2024.11.010_bib16","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archophthalmol.2011.130","article-title":"Periocular topotecan for intraocular retinoblastoma","volume":"129","author":"Mallipatna","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib17","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.4103\/ijo.IJO_737_18","article-title":"Periocular topotecan for vitreous seeds in retinoblastoma","volume":"66","author":"Sthapit","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib18","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/bjophthalmol-2017-310641","article-title":"Intravitreal topotecan in the management of refractory and recurrent vitreous seeds in retinoblastoma","volume":"102","author":"Rao","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib19","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.ophtha.2024.04.022","article-title":"Intravitreal topotecan for vitreous seeds in retinoblastoma: a long-term review of 91 eyes","volume":"131","author":"Sen","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.11.010_bib20","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.3928\/01913913-20230110-01","article-title":"Intravitreal topotecan 90 \u03bcg for recurrent solid retinoblastoma tumors is effective and not toxic","volume":"60","author":"Abramson","year":"2023","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"10.1016\/j.oret.2024.11.010_bib21","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/bjophthalmol-2020-318529","article-title":"Evaluation of intravitreal topotecan dose levels, toxicity and efficacy for retinoblastoma vitreous seeds: a preclinical and clinical study","volume":"106","author":"Bogan","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib22","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1016\/j.ophtha.2006.06.018","article-title":"The International Classification of Retinoblastoma predicts chemoreduction success","volume":"113","author":"Shields","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2024.11.010_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ohc.2004.11.003","article-title":"Intraocular retinoblastoma: the case for a new group classification","volume":"18","author":"Linn","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.oret.2024.11.010_bib24","series-title":"AJCC Cancer Staging Manual","first-page":"819","article-title":"Retinoblastoma","author":"Mallipatna","year":"2017"},{"key":"10.1016\/j.oret.2024.11.010_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamaophthalmol.2013.7666","article-title":"Intravitreal melphalan for persistent or recurrent retinoblastoma vitreous seeds: preliminary results","volume":"132","author":"Shields","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/IAE.0000000000002782","article-title":"Toxicity and efficacy of intravitreal melphalan for retinoblastoma: 25 \u03bcg versus 30 \u03bcg","volume":"41","author":"Liao","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.oret.2024.11.010_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26696","article-title":"Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era","volume":"64","author":"Berry","year":"2017","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.oret.2024.11.010_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-199807000-00006","article-title":"Topotecan in pediatric patients with recurrent and progressive solid tumors: a Pediatric Oncology Group phase II study","volume":"20","author":"Nitschke","year":"1998","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.oret.2024.11.010_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10384-020-00743-2","article-title":"Comparison of intravitreal melphalan with and without topotecan in the management of vitreous disease in retinoblastoma","volume":"64","author":"Kiratli","year":"2020","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.oret.2024.11.010_bib31","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0731-7085(97)00022-8","article-title":"Stability and compatibility of topotecan hydrochloride for injection with common infusion solutions and containers","volume":"16","author":"Craig","year":"1997","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.oret.2024.11.010_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/13816810.2020.1776336","article-title":"Optimizing the storage of chemotherapeutics for ophthalmic oncology: stability of topotecan solution for intravitreal injection","volume":"41","author":"Bossacoma","year":"2020","journal-title":"Ophthalmic Genet"},{"key":"10.1016\/j.oret.2024.11.010_bib33","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/jps.2600740329","article-title":"Stability of melphalan solutions during preparation and storage","volume":"74","author":"Bosanquet","year":"1985","journal-title":"J Pharm Sci"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024005402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653024005402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:07:22Z","timestamp":1762628842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653024005402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2468653024005402"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2024.11.010","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal Melphalan versus Topotecan for Vitreous Seeds in Retinoblastoma","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2024.11.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}